Valink Therapeutics Analysis
What is Valink Therapeutics?
Valink Therapeutics develops novel therapeutics that effectively target tumors while sparing healthy tissue. Their proprietary LiliumX® platform utilizes synthetic protein biology, high-throughput functional screening, and AI to discover bispecific antibody-drug conjugates. The company focuses on creating drugs that minimize side effects and improve treatment outcomes for cancer patients.
HQ Country
Cambridge, United States
Employees
11-50
Founded
2020
Product Features & Capabilities
- LiliumX® platform for drug discovery
- Bispecific antibody-drug conjugates
- Oncology-focused therapeutic programs
